Insider buying was on holiday during the New Year’s break as iStock identified records for only 31 companies. However, that doesn’t mean we don’t have anything to write about this week.
Lexmark International Inc. (NYSE:LXK) is our insider purchase choice today; albeit, it’s the winner in a pool of slim-pickings where fives look like tens. In case you don’t have one or know, Lexmark is a developer, manufacturer and supplier of printing, imaging, device management, managed print services, document workflow, and also provides business process and content management solutions.
This author has probably spent thousands of dollars on Lexmark ink! Ugh.
[Related -Futures Up On China Moves; Sourcefire, Inc. (FIRE) Surges On Cisco Systems, Inc. Buyout]
Before we get deeper into our look at LXK, if you believe insiders possess knowledge the average investor never will – they do – and would be interested in a portfolio comprised of stocks with insider buying, then you might want to check out iStock’s new Insiders’ Circle.
Hot Low Price Stocks To Buy Right Now: Polaris Industries Inc. (PII)
Polaris Industries Inc. designs, engineers, and manufactures off-road vehicles. It offers all terrain vehicles and side-by-side vehicles for recreational and utility use; snowmobiles; and on-road vehicles, including motorcycles and low emission vehicles. The company also provides replacement parts and accessories, including winches, bumper/brushguards, plows, racks, mowers, tires, pull-behinds, cabs, cargo box accessories, tracks, and oil for off-road vehicles; covers, traction products, reverse kits, electric starters, tracks, bags, windshields, oil, and lubricants for snowmobiles; and saddle bags, handlebars, backrests, exhaust, windshields, seats, oil, and various chrome accessories for motorcycles. Polaris Industries sells its products through dealers and distributors primarily under the RANGER, RANGER RZR, RANGER Crew, Victory Vision, Victory Cross Roads, Polaris RUSH, and Cross Country trade marks. In addition, it markets helmets, jackets, bibs and pants, leathers, a nd hats through dealers and distributors, as well as online under the Polaris brand name. The company principally operates in the United States and Canada. Polaris Industries Inc. was founded in 1987 and is headquartered in Medina, Minnesota.
- [By Stephen Quickel]
Polaris Industries (PII)
A great stock from 2011-13, this maker of snowmobiles and all-terrain vehicles suddenly swooned from $146 to $119 this January, but now has rebounded to $138, with a $160 price in analysts’ sights. Seven of ten call it a Strong Buy, two a Buy.
- [By Dan Caplinger]
Vail Resorts (NYSE: MTN ) will release its quarterly report on Monday, and already, investors are celebrating an early cold snap in the American West by sending the resort company’s stock toward yearly highs. To an even greater extent than winter-equipment makers Polaris Industries (NYSE: PII ) and Arctic Cat (NASDAQ: ACAT ) , Vail Resorts relies on a solid snow season in order to get visitors to come to its ski properties and stay at its resorts.
- [By Jonas Elmerraji]
Shareholders in Polaris Industries (PII) are having a stellar year in 2013; shares of the $9 billion ATV manufacturer are up more than 55% since the calendar flipped over to January. But even if you missed the move, you shouldn’t ignore this stock. PII looks like it’s still got higher ground ahead of it.
That’s because Polaris is currently forming an ascending triangle pattern, a bullish price setup that’s formed by a horizontal resistance level above shares at $137 and uptrending support to the downside. Basically, as PII bounces in between those two technical levels, it’s getting squeezed closer and closer to a breakout above $137. When that happens, we’ve got a buy signal in shares.
Berkshire is currently forming a descending triangle pattern, the bearish opposite of the ascending triangle in PII. The descending triangle is formed by downtrending resistance pushing down from above shares and horizontal support to the downside, in this case at $111. A breakdown through $111 is Berkshire’s sell signal.
A parabolic drop in relative strength since June indicates that Berkshire has been woefully underperforming the S&P 500 in recent months — you can see it from the stock’s inability to make new highs in November. Buyers look anemic here, but failure to catch a bid at $111 is the start of something bigger.
Don’t sell unless Warren Buffett’s baby unless shares fall through that price floor.
- [By Jonathan Berr]
One thing to note: Harley does have a new rival: Indian motorcycles — a brand being resurrected by Polaris Industries (PII).
The return of the brand, which went out of business in the 1950s, has generated lots of buzz. It was featured on the A&E reality show American Pickers and has captured the attention of the motorcycle trade press.
Hot Low Price Stocks To Buy Right Now: TMS International Corp.(TMS)
TMS International Corp., through its subsidiaries, provides outsourced industrial services to steel mills in North America and internationally. It principally offers scrap management and preparation; semi-finished and finished material handling; metal recovery and slag handling, processing, and sales; surface conditioning; raw materials procurement and logistics; and proprietary software-based raw materials cost optimization services. The company?s scrap management and preparation services include the provision of inspection, preparation, and delivery of raw materials, primarily scrap, as well as inventory control through logistics management services. Its semi-finished and finished material handling services comprise handling and transportation of semi-finished and finished steel products, such as steel slabs, billets, and plates; metal recovery and slag handling, processing, and sales services consist of recycling and processing the slag to recover metallic material; an d surface conditioning services include removing imperfections from semi-finished steel products to be used in applications that require unblemished finishes, such as household appliances and automobiles. The company?s raw materials procurement and logistics services comprise purchasing, on behalf of customers, raw material inputs, including ferrous scrap, scrap substitutes, coke, coal, ore, non-ferrous metals, ferro-alloys, and other raw materials used in steel making, as well as arranging point-to-point delivery logistics. Its proprietary software-based raw materials cost optimization services consist of development and marketing of Scrap OptiMiser and GenBlend software applications that aid mills in the planning, procurement, and utilization of ferrous scrap and scrap substitutes. The company was founded in 1926 and is headquartered in Glassport, Pennsylvania. TMS International Corp. is a subsidiary of Onex Corporation.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on TMS International (NYSE: TMS ) , whose recent revenue and earnings are plotted below.
- [By Rich Duprey]
Outsourced industrial services provider TMS International (NYSE: TMS ) announced on Friday its second-quarter dividend of $0.10 per share, the same rate it paid last quarter after initiating the payout.
Hot Low Price Stocks To Buy Right Now: Interpublic Group of Companies Inc (IPG)
The Interpublic Group of Companies, Inc. (Interpublic), incorporated in September 1930, is a global advertising and marketing services companies. Interpublic’s companies specialize in consumer advertising, digital marketing, communications planning and media buying, public relations and specialized communications disciplines. The Company has two segments: Integrated Agency Networks (IAN) and Constituency Management Group (CMG). IAN is comprised of McCann, Draftfcb, Lowe, Mediabrands and its domestic integrated agencies. CMG is comprised of a number of its specialist marketing services offerings. During the year ended December, 31, 2011, it completed 22 acquisitions, which included purchases of controlling interests in previously unconsolidated subsidiaries. Of these acquisitions, 18 are included in IAN operating segment and four are included in CMG operating segment. All acquired agencies have been integrated into one of its global networks or existing agencies. The acqu isitions included service creative agencies in Australia, a public relations firm in Brazil, digital and direct marketing agencies in the United Kingdom, a healthcare communications firm in Germany and a social media agency in the United States. In November 2013, Interpublic Group of Companies Inc’s MRM, a global digital and direct agency within McCann Worldgroup, a unit of the Interpublic Group of Companies, acquired the Brazilian agency E/OU. In January 2014, Interpublic Group of Companies Inc announced that its division Lowe and Partners, announced the acquisition of the global digital network Profero.
The Company’s agencies create customized marketing programs for companies. The Company has three global networks: McCann Worldgroup (McCann); Draftfcb and Lowe & Partners (Lowe), that provide integrated, advertising and marketing solutions for clients, and two global media services companies, UM and Initiative, operating under the Mediabrands umbrella. It pre mier also has domestic integrated and interactive agencies. ! Its solutions vary from project-based activity involving one agency to long-term, integrated campaigns created by multiple IPG agencies working together.
McCann offers a range of communications tools and resources to companies and brands. McCann Erickson Advertising has operations in over 100 countries. MRM Worldwide is its global digital and customer relationship management (CRM) network. Momentum Worldwide is engaged in experiential marketing and promotions, as is McCann Healthcare Worldwide in healthcare communications. Draftfcb is an agency model for clients seeking creative and accountable marketing programs delivered in a media-neutral manner under a unified, integrated business.
Lowe is a creative agency. Lowe is developing ideas that connect with culture. Mediabrands delivers on the scale and breadth of its media capabilities. UM and Initiative seek to deliver business results by advising clients on how to navigate an increasingly complex a nd digital marketing landscape. Specialist brands within Mediabrands focus on areas, such as the targeting and aggregation of audiences in the digital space, hyper-local marketing, media barter and a range of other capabilities.
The Company’s domestic integrated independent agencies include agency brands, including Campbell-Ewald, Hill Holliday, The Martin Agency and Mullen. The marketing programs created by the group incorporate all media channels, CRM, public relations and other marketing activities and have helped build some of the brands in the United States, across all sectors and industries. It has marketing specialists across a range of disciplines. These include Jack Morton (experiential marketing), Octagon (sports marketing), public relations agencies, such as Weber Shandwick and GolinHarris, FutureBrand (corporate branding), and its digital specialist agencies, led by R/GA and HUGE. Its healthcare communications specialists reside within its three gl obal brands: McCann, Draftfcb and Lowe.
- [By Monica Gerson]
The Interpublic Group of Companies (NYSE: IPG) is projected to report its Q3 earnings at $0.18 per share on revenue of $1.71 billion.
Kansas City Southern (NYSE: KSU) is estimated to report its Q3 earnings at $1.11 per share on revenue of $622.27 million.
- [By Rich Smith]
On a relatively slow day for Defense Department business Tuesday, a sizable contract was awarded to a company you don’t often think of as belonging to the military-industrial complex: McCann Worldgroup, a subsidiary of giant, globetrotting ad agency Interpublic (NYSE: IPG ) — and just in time for the return of Mad Men.
- [By Rich Smith]
After bulling through March with strong spending despite the sequester, Pentagon contract awards fell off a cliff in early April. And what little money there was to spread around was often showered upon non-traditional recipients such as Madison Avenue advertising firm Interpublic Group (NYSE: IPG ) .
Hot Low Price Stocks To Buy Right Now: Foundation Medicine Inc (FMI)
Foundation Medicine, Inc., incorporated on November 12, 2009, is a commercial-stage company. The Company is focused on fundamentally changing the way patients with cancer are treated. The Company’s platform includes methods and algorithms for analyzing tumor tissue samples across all types of cancer, as well as information aggregation and concise reporting capabilities. Its products provide genomic information about each patient’s individual cancer, enabling physicians to optimize treatments in clinical practice and enabling biopharmaceutical companies to develop targeted oncology therapies more effectively.
FoundationOne, its first clinical product, is, to its knowledge, the only commercially available comprehensive molecular information product designed for use in the routine care of patients with cancer. In addition, the Company is considered a non-contracting provider by commercial third-party payors because it has not entered into specific contracts to provide FoundationOne to their covered patients, and as a result it takes on primary responsibility for obtaining reimbursement on behalf of patients.
- [By John Udovich]
Small cap healthcare information stocks Everyday Health Inc (NYSE: EVDY), Foundation Medicine Inc (NASDAQ: FMI) and CollabRx Inc (NASDAQ: CLRX) help consumers and healthcare professionals deal with the increasing amount of information overload that comes with treating or figuring out how to treat patients.
- [By James E. Brumley]
It wouldn’t be fair to say there’s nothing like it “out there”, because there is. A company called Foundation Medicine Inc. (NASDAQ:FMI) has developed a similar/comparable app. The CLRX version of the solution appears superior in most ways, however, if for no other reason than because of the projected revenue growth the company is apt to see.
- [By Bryan Murphy]
Eat your heart out Foundation Medicine Inc. (NASDAQ:FMI). And WebMD Health Corp. (NASDAQ:WBMD)? Don’t even bother trying. CollabRx Inc. (NASDAQ:CLRX) has built a better mousetrap, and if yesterday’s announcement is a sign of things to come, CLRX could prove to be a very compelling investment.
Hot Low Price Stocks To Buy Right Now: Express Inc. (EXPR)
Express, Inc. operates specialty retail stores in the United States. The company?s stores offer apparel and accessories for women and men between 20 and 30 years old across various aspects of the lifestyles comprising work, casual, jeanswear, and going-out occasions. It also sells gift cards. As of January 29, 2011, the company operated 591 stores, including 547 dual-gender stores, 25 women?s stores, and 19 men?s stores located primarily in high-traffic shopping malls, lifestyle centers, and street locations in 47 states throughout the United States, the District of Columbia, and Puerto Rico. In addition, it operates seven Express stores in Saudi Arabia, Kuwait, and the United Arab Emirates through its Development Agreement with Alshaya Trading Co.; and sells its products through e-commerce Website, express.com. The company was formerly known as Express Parent LLC and changed its name to Express, Inc. in May 2010. Express, Inc. was founded in 1980 and is headquartered in C olumbus, Ohio.
- [By WWW.DAILYFINANCE.COM]
Rogelio V. Solis/APMississippi Attorney General Jim Hood, speaking to a business group in Jackson, Miss., in October 2012. WASHINGTON — Mississippi has sued credit reporting giant Experian (EXPR), alleging sweeping errors in the company’s data and routine violations of consumer protection laws. Mississippi’s action — and a previously unreported multistate investigation of credit bureaus led by Ohio — represent a significant new legal challenge to the industry. Mississippi Attorney General Jim Hood’s complaint against Experian Information Solutions was filed without fanfare last month in a Biloxi state courthouse and transferred to Mississippi federal court late last week. The lawsuit accuses Experian of knowingly including error-riddled data in the credit files of millions of Americans, jeopardizing their ability to obtain loans, employment-related background checks and sensitive government security clearances. Experian has even wrongly reported that consumers are on a federal terrorism watch list, the lawsuit said. Both Experian and a spokesman for its trade group, the Consumer Data Industry Association, declined to discuss the litigation or related questions about the quality of the company’s data. Experian warned investors earlier this year that the U.S. Consumer Financial Protection Bureau and its British counterpart were regulatory agencies responsible for protecting consumers and said, “It remains uncertain how these bodies may affect our credit and consumer business processes and business models in the future.” Experian told investors that, to the best of its knowledge, it complies with data protection requirements, but it warned that, “We might fail to comply with international, federal, regional, provincial, state or other jurisdictional regulations, due to their complexity, frequent changes or inconsistent application and interpretation.” Despite the errors, the Mississippi lawsuit said, Experian provides no straightforward way for consumers
- [By WWW.DAILYFINANCE.COM]
Justin Sullivan/Getty Images NEW YORK and DETROIT — U.S. banks looking to get in on a booming market for financing new-car sales have run into a formidable competitor: the auto manufacturers themselves. Financing arms of car companies, including Toyota Motor (TM), Honda Motor (HMC) and Ford Motor (F), made half of all new U.S. car loans in the first quarter, up from 37 percent a year earlier and the largest percentage of the market in four years, according to credit data firm Experian (EXPR). These companies also write the vast majority of leases, which contributed a record 26 percent of new car sales in the quarter, up from 23 percent last year and 20 percent in 2012. The financing arms are providing subsidies from the manufacturers, lowering monthly payments and extending loan terms to make it easier for buyers to drive away in a shiny, new vehicle. As a result, major banks are increasingly moving into riskier parts of the market to make loans. U.S. Bancorp (USB), for example, for the first time ever decided to start financing used cars, an area of the market that the automakers’ finance companies have little interest in. It also started offering loans to less creditworthy borrowers. And Wells Fargo (WFC) has been leveraging off a nationwide deal with General Motors (GM) to provide loans subsidized by the No. 1 U.S. automaker. Wells sees this as a way to gain more of the used car loan business at GM dealerships. The aggressive push by car companies is beginning to raise questions among industry analysts and consultants about whether it is sustainable. If interest rates rise, the automakers could find the incentives too costly unless they are prepared to take a hit to profits — with any pullback in the deals being offered customers running the risk of hurting demand. And, if used car prices weaken, the financing units could be hit with losses on vehicles coming back from leases and repossessions. The automakers’ financing companies are doing sub
- [By Maria Armental var popups = dojo.query(“.socialByline .popC”); popups.forEach]
Among the companies with shares expected to actively trade in Friday’s session are Express Inc.(EXPR), OpenTable Inc.(OPEN) and Priceline Group Inc.(PCLN)
- [By WWW.DAILYFINANCE.COM]
Stocks ended a mini-losing streak on Friday, led by upbeat news from Intel (INTC). The Dow Jones industrial average (^DJI) rose 41 points, after sliding more than 200 over the previous two days. The Nasdaq composite (^IXIC) gained 13 and the Standard & Poor’s 500 index (^GPSC) added 6 points. Those modest gains did little to trim the loss for the week. The major averages posted their biggest weekly declines in more than two months. Intel is a component of all three big indexes, and it jumped 7 percent after raising its revenue guidance for the current quarter. The company sees stronger business demand for PCs than it previously expected. Intel shares are up 23 percent over the past six months. The Intel news had a ripple effect. Computer maker Hewlett-Packard (HPQ) rose more than 5 percent and Microsoft (MSFT) gained 1½ percent. Part of the increased demand Intel points to is tied to corporate buyers who need to replace their Windows XP machines, because Microsoft has stopped providing technical support for that platform. But Apple (AAPL) lost more than 1 percent. The stock is down since its 7-for-1 stock split took effect on Monday. There were two other big stories that had some legs beyond the companies directly involved. Open Table (OPEN) agreed to be acquired by Priceline (PCLN) for $2.6 billion. Open Table, which provides restaurant reservations, jumped 48 percent. Other online service providers rode the coattails of that deal. Yelp (YELP) gained 14 percent and Groupon (GRPN) gained 4 percent. In the retail arena, Express (EXPR) jumped 21 percent after a private equity firm took a 9.9 percent stake in the teen retailer and indicated it may make a buyout offer. That gave a boost to Aeropostale (ARO) and American Eagle (AEO), which both rose more than 2 percent. Abercrombie & Fitch (ANF) gained 1½. Elsewhere, International Game Technology (IGT) gained 10½ percent on a Reuters report that a bidding war could erupt for
Hot Low Price Stocks To Buy Right Now: Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., incorporated on July 22, 1980, biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. The Company’s product candidates include Eteplirsen, AVI-6002, AVI-6003, and AVI-7100. As of December 31, 2011, the Company primarily focused on advancing the development of its Duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen, which is in a Phase IIb trial. The Company is also focused on developing therapeutics for the treatment of infectious diseases, including its lead infectious disease programs aimed at the development of drug candidates for the Ebola and Marburg hemorrhagic fever viruses. The Company’s program focuses on the development of disease-modifying therapeutic candidates for Duchenne muscular dystrophy (DMD). The Company initiated a Phase IIb trial for eteplirsen in August 2011 with an objective of initiating a pivotal trial subsequent to 2011.
The Company is also leveraging the capabilities of its RNA-based technology platforms to develop therapeutics for the treatment of infectious diseases. The Company’s RNA-based drug programs are clinically evaluated for the treatment of DMD and have also demonstrated anti-viral activity in infectious diseases such as Ebola, Marburg and H1N1 influenza in certain animal models. The Company’s lead product candidates are at various stages of development.
Duchenne Muscular Dystrophy Program
The Company’s lead program is designed to address specific gene mutations that result in DMD by forcing the genetic machinery to skip over an adjacent contiguous piece of RNA and, thus, restore the ability of the cell to express a new, truncated but functional, dystrophin protein.
Eteplirsen is an antisense PMO-based therapeutic in clinical development for the treatmen t of individuals with DMD who have an error in the gene codi! ng for dystrophin that can be treated by skipping exon 51. Eteplirsen targets the frequent series of mutations that cause DMD. Eteplirsen has been granted orphan drug designation in the United States and European Union. In addition to the Company’s lead product candidate, eteplirsen, the Company is actively pursues development of a product candidate that skips exon 45 through an IND-enabling collaboration.
The Company is implementing its RNA-based technology platforms in its anti-viral programs for the development of therapeutics to treat viruses, such as Ebola, Marburg and influenza. The Company’s arrangement with DoD supporting the development of the Company’s Ebola and Marburg virus drug candidates provides funding for all clinical and licensure activities necessary to obtain approval of a New Drug Application (NDA), by the United States Food and Drug Administration (FDA), if DoD exercises all of its options under the arrange ment. During the year ended December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and is exploring funding opportunities or partnerships with DHHS and industry collaborators to advance its development.
The Company’s anti-viral therapeutic programs use the Company’s translation suppression technology and applies its PMOplus chemistry backbone, an advanced generation of its base PMO chemistry backbone that selectively introduces positive backbone charges to improve selective interaction between the drug and its target. The Company’s translation suppressing technology is based on Translation Suppressing Oligomers (TSOs), which are PMO-based compounds that stop or suppress the translation of a specific protein by binding to their specific target sequence in mRNA.
The Company is pursuing development and regulatory approval of its Ebola and Marburg hemorrhagic fever virus product candidates under the FDA’s Animal Rule. The Co mpany’s lead product candidate against the Ebola virus infec! tion is A! VI-6002. For Marburg virus infection, the Company’s lead product candidate has been AVI-6003. In February 2012, the Company announced that the Company received approval from the FDA to remove one of the two oligomers composing AVI-6003 and proceed with a single oligomer approach, AVI-7288, given that efficacy in non-human primates has been demonstrated to be attributable to this single oligomer. The Company is exploring the feasibility of alternate routes of administration of its Ebola and Marburg drug candidates, and at DoD’s invitation, the Company is developing a proposal to be submitted for a study to demonstrates feasibility of the intramuscular route.
AVI-6002, which is a combination of AVI-7537 and AVI-7539, is designed for post-exposure prophylaxis after documented or suspected exposure to the Ebola virus. The Company is evaluating the feasibility of developing AVI-7537 as a single agent for the post-exposure prophylaxis after documented or suspected exp osure to Ebola virus. AVI-6003, which is a combination of AVI-7287 and AVI-7288, is designed for post-exposure prophylaxis after documented or suspected exposure to Marburg virus. In February 2012, the Company announced that the Company received approval from the FDA to proceed with AVI-7288 as a single agent against Marburg virus infection. The Company intends to proceed with dosing AVI-7288 in the Phase I multiple ascending dose studies and in non-human primate studies.
The Company’s anti-viral therapeutic programs are also focused on the development of the Company’s product candidates designed to treat pandemic influenza viruses. AVI-7100 is the Company’s lead product candidate for the treatment of influenza and employs its PMOplus technology. In June 2011, the Company initiated dosing of AVI-7100 through intravenous infusion in single-ascending doses in up to 48 healthy adult volunteers. As of December 31, 2011, the Company pau sed its clinical development efforts on AVI-7100 and are exp! loring fu! nding opportunities or partnerships to advance its development.
The Company has developed three new phosphorodiamidate-linked morpholino oligomers (PMO)-based chemistry platforms in addition to its original PMO-based technology. The Company’s PMO-based molecules are designed to sterically block the access of cellular machinery to pre-mRNA and mRNA without degrading the RNA. Through this selective targeting, two distinct biologic mechanisms of action can be initiated: modulation of pre-mRNA splicing and inhibition of mRNA translation.
The Company competes with GlaxoSmithKline plc, Toyama Chemical, Alnylam Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals, Inc., Prosensa, and Santaris Pharma A/S.
- [By Rich Bieglmeier]
It’s not every day that a stock is up 40% but still might have another 50%+ to go. However, that is the case with Sarepta Therapeutics Inc. (NASDAQ:SRPT).
- [By Ben Levisohn]
Shares of Sarepta Therapeutics (SRPT) and Plug Power (PLUG) are falling in after-hours trading after the two companies announced plans to sell more shares.
Sarepta Therapeutics said it plans to sell as much as $100 million in new shares and also granted underwriters a 30-day option to buy as much as $15 million more. Plug Power announced a sale, but said the amount would depend on “market and other conditions.”
Shares of Sarepta Therapeutics have fallen 4.5% to $38.79 at 4:49 p.m. in after-hours trading, while Plug Power has tumbled 8.7% to $6.12.
- [By Ben Levisohn]
Shares of Sarepta Therapeutics (SRPT) have surged more than 40% today after the biotech company said that the FDA would consider one of its drugs sooner than expected. The Wall Street Journal explains:
Sarepta Therapeutics Inc. said Monday that it would submit a new drug application to the U.S. Food and Drug Administration by the end of the year for its experimental treatment for a fatal degenerative disease that afflicts children.
Shares surged more than 50% in early trading as the news seemed to mark a reversal in the company’s dealings with the FDA.
Late last year, the agency suggested that the company needed to do a larger, late-stage study for eteplirsen, which treats Duchenne muscular dystrophy treatment, a fatal disease that destroys muscle tissue in children and afflicts about one in every 3,500 boys born across the globe, according to Sarepta.
Leerink’s Joseph Schwartz and Paul Matteis are “intrigued” by the FDA’s decision:
We are intrigued that the FDA is allowing [Sarepta] to start a confirmatory eteplirsen study with an open-label design, although we are cautious that the FDA is also encouraging the company to start placebo-controlled studies for other exon-skippers as soon as possible in order to build the case for eteplirsen approval. We are cautious that the FDA will have the same concerns that were highlighted in today’s press release when it reviews eteplirsen in 2015, and may opt to continue to wait for more controlled data to be convinced. Importantly, the FDA believes it is not appropriate to exclude patients who lose ambulation while on drug from the analysis (modified intent-to- treat), which has been key for eteplirsen to compare favorably to historical control (which includes such patients). The FDA has shown a willingness to be patient and wait for more compelling/controlled data before approving eteplirsen so we see the risk that the FDA continues to do so beyo
- [By Jake L’Ecuyer]
Leading and Lagging Sectors
Monday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Sarepta Therapeutics (NASDAQ: SRPT) and STAAR Surgical Company (NASDAQ: STAA). In trading on Monday, basic materials shares were relative laggards, down on the day by about 0.45 percent.
Hot Low Price Stocks To Buy Right Now: PIMCO Intermediate Municipal Bond Strategy Fund (MUNI)
PIMCO Intermediate Municipal Bond Strategy Fund, formerly, PIMCO Intermediate Municipal Bond ETF (the Fund), seeks to achieve its investment objective by investing at least 80% of its assets in a diversified portfolio of debt securities whose interest is, in the opinion of bond counsel for the issuer at the time of issuance, exempt from federal income tax (Municipal Bonds). Municipal Bonds are issued by or on behalf of states and local governments and their agencies, authorities and other instrumentalities The Fund may only invest in the United States dollar-denominated investment grade debt securities, rated Baa or higher by Moody’s, or equivalently rated by S&P or Fitch. It may invest 25% or more of its total assets in Municipal Bonds that finance similar projects, such as those relating to education, health care, housing, transportation and utilities. The Fund’s investment advisor is Pacific Investment Management Company LLC (PIMCO). Advisors’ Opinion:
- [By Mary Anne & Pamela Aden]
The ones we like best and recommend buying are the iShares 20+ year Treasury Bond (TLT), the iShares 10-20 year Treasury Bond (TLH), Proshares Ultra 20+ year Treasury (UBT) and Pimco Intermediate Muni Bond strategy ETF (MUNI).
Hot Low Price Stocks To Buy Right Now: Quicksilver Resources Inc. (KWK)
Quicksilver Resources Inc., an independent oil and gas company, engages in the acquisition, exploration, development, and production of onshore oil and gas in North America. The company focuses primarily on unconventional reservoirs, such as fractured shales, coal beds, and tight sands. It owns producing oil and natural gas properties principally in Texas, Colorado, Wyoming, and Montana, as well as in Alberta and British Columbia. The company primarily holds interests in assets covering an area of approximately 140,000 net acres located in the Barnett Shale, Fort Worth basin, north Texas; exploratory licenses covering an area of approximately 130,000 net acres located in the Horn River basin of northeast British Columbia; and assets covering an area of approximately 36,929 net undeveloped acres located in the Horseshoe Canyon, southern and central Alberta. As of December 31, 2011, it had total proved reserves of approximately 2.8 trillion cubic feet of natural gas equivale nts. The company was founded in 1997 and is headquartered in Fort Worth, Texas.
- [By Vanina Egea]
Backed by the successful performance registered for fiscal year 2013, Southwestern Energy announced the acquisition of approximately 312,000 net acres in northwest Colorado targeting crude oil, natural gas liquids and natural gas contained in the Niobrara formation from Quicksilver Resources (KWK) and SWEPI LP, a wholly owned subsidiary of Royal Dutch Shell (RDS.A) for approximately $180 million. The transaction is expected to close in the second quarter of 2014.
- [By Aaron Levitt]
Over the long term, analysts speculate that FST will sell off the remaining chunk of its non-core properties in order to focus strictly on the Eagle Ford. If it’s successful, the current share price of this $3.30 could be more valuable than a winning lotto ticket.
Energy Stocks Under $10 to Buy Now: Quicksilver Resources (KWK)
Quicksilver Resources (KWK) is the last name on our list of cheap energy stocks under $10 … and it could also be one of the best rocket-ship plays for rising natural gas. KWK focuses primarily on unconventional reservoirs, such as shale formations, coal beds and tight sands. As such, about 99% of the company’s production comes from natural gas and NGLs.
Hot Low Price Stocks To Buy Right Now: View Systems Inc (VSYM)
View Systems, Inc. (View Systems), incorporated on July 25, 2003, develops, produces and markets computer software and hardware systems for security and surveillance applications. The Company has penetrated four market segments for this product: correctional facilities, judicial facilities, probation offices and federal facilities in the Mid-Atlantic States, the West Coast and the South. The Company’s products and services include ViewScan Concealed Weapons Detection System, Multi-Mission Mobil Video (MMV), ViewMaxx Digital Video System, Additional Applications and Integration of ViewScan and ViewMaxx, the MINI, Network Services, FiberXpress, Inc., Visisys Ltd. and Training and Service Programs.
ViewScan Concealed Weapons Detection System
ViewScan is sold under the name Secure Scan, is a walk-through concealed weapons detector, which uses data sensing technology to pinpoint the location, size and number of concealed weapons. This walk-through po rtal is controlled by a master processing board and a personal computer based unit which receives magnetic and video information and combines it in a manner that allows the suspected location of the weapon to be stored electronically and referenced. ViewScan products are distributed in three basic configurations; stand-alone units, portable units and integrated door systems. ViewScan is designed to overcome the traditional shortcomings of electromagnetic induction scanners.
Multi-Mission Mobil Video
The MMV is a lightweight, wireless camera system housed in a tough, waterproof body. The camera system sends back real-time images to a computer or video monitor at the command post located outside the exclusion zone or containment area. The MMV also uses an Extension Link which is a separate transmitter and receiving system that increases the operating range of the MMV.
The Company has incorporated a video encryption feature that allows fir st responders to transmit on-scene video to the command post! without the data being intercepted by unwanted parties. The MMV is fully deployed by one person in a stand-alone configuration in less than 10 minutes. The system is battery operated and can operate for eight continuous hours using one set of spare camera batteries.
ViewMaxx Digital Video System
ViewMaxx is a high-resolution, digital video recording and real-time monitoring system. This system can be scaled to meet a specific customer’s needs by using anywhere from one camera up to 32 surveillance cameras per each ViewMaxx unit. The system uses a video capture card recording which translates closed-circuit television analog video data (a format normally used by broadcasters for national television programs) to a computer readable digital format to be stored on direct access digital disk devices rather than the conventional television format of video tape. ViewMaxx offers programmable recording features that can eliminate the unnecessary storage of non-critical image data.
Additional Applications and Integration of ViewScan and ViewMaxx
The Company offers integration of other products with ViewScan or ViewMaxx. Its product can be interfaced with ViewScan and/or ViewMaxx to limit individual access to an area. ViewScan and/or ViewMaxx can be coupled with magnetic door locks to restrict access to a particular area. It also offers a central monitoring or video command center for ViewScan or ViewMaxx products.
The MINI (Mobile Intelligent Network Informer) is a portable, wireless watchdog communication device that checks for intrusion into uninhabited areas such as foreclosed houses, storage spaces and vacation homes. The MINI senses motion and sends text messages to a user’s cell phone. Property and remote assets may be guarded by this device that requires no plug-in electricity, no physical phone line and no monitoring service. The MINI runs on batteries and one configuration of the system can even send a photo of the in! truder to! the user’s cell phone. Camera settings can be controlled and changed via short message service (SMS) commands. It licenses the MINI from its manufacturer and acts as a distributor.
View Systems Inc. Network Services group supplied integrated electronic security and control systems. It supplied for commercial and industrial applications throughout the Mid Atlantic area.
FiberXpress, Inc. sells specialist data network related products. It sells its products through its Internet Website.
During the year ended December 31, 2011, there were no revenues from this partnership. The Company’s partnership with Visisys, Ltd. has been terminated.
Training and Service Programs
The Company offers support services for our products, which includes on site consulting/planning with customer architect and engineers; installation and technical support; installation and technical support, and cand. The Company’s family of products offers government and law enforcement agencies, commercial security professionals, private businesses and residential consumers an enhanced surveillance and detection capacity. Its ViewScan products and technology can be used where there is a temporary requirement for real-time weapons detection devices in areas where a permanent installation is prohibitive or impractical.
A primary market for the Company’s ViewScan portal is federal and state government courthouses, county and municipal buildings, and correctional facilities. The Company has installed its ViewScan weapons detection products in a variety of court house situations. The MMV product’s market includes National Guard units and first response agencies such as fire, police, SWAT, and homeland security response teams.
The Company competes with Ranger Security Scanners, Inc., Garrett Electronics, Inc., CE IA SpA, Sensormatic Corporation, NICE Systems, Ltd. and Inte! gral Syst! ems.
- [By James E. Brumley]
While it’s tragic that it took a string of tragedies to make school safety and security a priority in the United States, it can’t be denied that the topic has been put front and center – school systems everywhere are asking themselves tough questions, mainly focusing on what can be done quickly and cost-effectively to secure school buildings. Part of that discussion has put companies like OSI Systems, Inc. (NASDAQ:OSIS), American Science & Engineering, Inc. (NASDAQ:ASEI), and View Systems Inc. (OTCBB:VSYM) in the limelight. The three organizations all make security screening and weapons detection systems. If you’ve flown from anywhere inside the United States anytime since 2003, odds are pretty good you or your luggage passed through equipment made by ASEI or OSIS.
- [By James E. Brumley]
It’s worth noting that it’s not their fault. The measures needed to defend a primary and secondary school are foreboding, and can be expensive, and therefore are politically unpopular. Sadly though, each school shooting victim’s death chips away at the disdain for physical barriers and checkpoints at a school’s doors. Enter View Systems Inc. (OTCBB:VSYM).
- [By John Udovich]
Small cap security and surveillance stocks like Vimicro International Corporation (NASDAQ: VIMC), TASER International, Inc (NASDAQ: TASR), Kratos Defense & Security Solutions, Inc (NASDAQ: KTOS) and View Systems Inc (OTCBB: VSYM) have been producing a steady stream of news lately for investors and traders alike to digest. After all, the entire security and surveillance industry is pretty vast as it would include everything from airport scanners to security cameras or monitoring equipment to actual weapons for domestic or national defense to software securing everyone’s personal or online data to the technology groups like the NSA and other “Big Brother” agencies use to spy on us. With that in mind, here is a look at the latest news from important small cap security and surveillance stocks:
- [By John Udovich]
Small cap security and surveillance stocks OSI Systems, Inc (NASDAQ: OSIS), Vimicro International Corporation (NASDAQ: VIMC), Analogic Corporation (NASDAQ: ALOG), Lifelock Inc (NYSE: LOCK) and View Systems Inc (OTCBB: VSYM) have been producing a steady flow of news lately that investors might want to take a closer look at. After all, the whole security and surveillance industry is pretty vast as it would include everything from airport scanners to security cameras to software securing everyone’s personal or online data. With that in mind, here is a look at the latest news from important small cap security and surveillance stocks: